Pharmafile Logo

The inescapable rise of patient-centricity

- PMLiVE

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.

Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on its promise to put patients at the heart of everything they do? Dennis O’Brien, Lucid CEO, believes we are making progress but still have a long way to go.

How do we achieve patient-centricity? Dennis believes we must not lose sight of patients. With the evolution of personalised medicine, we must also personalise the value that we deliver to patients. Dennis thinks that technology is the answer. “Tech provides the opportunity to analyse what patients look at on the internet, indicating their values.” However, this is only a starting point. “We’ve got to think like tech providers and think like consumers. If we can do that, we’ll build trusted communities that provide meaningful value. But we’re just not there yet. For some reason we’re scared to connect to patients. We need to get over it.”

Dennis thinks that achieving this requires a fundamental shift in mindset, moving the goal from outcomes to improving someone’s every-day life. “Patient-centricity is a relentless pursuit. The best players in this space will be those who understand that patient insight gives them a continual point of differentiation – and can track, analyse and respond to it quickly to deliver better value to patients.”

Read more about what Dennis and other industry thought leaders have to say on the inescapable rise of patient-centricity here.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.